OSM and Alzheimer disease: Compared to Aβ- CN, Aβ- MCI patients showed increased levels of oncostatin M (OSM; d = 0.58; q = 0.003) in plasma, which were also significantly increased in AD (d = 0.33; q = 0.006; see Table 3).